×
Join our live online event
How top hedge funds use news to make money
form the stock market & how ordinary people are
copying their strategies
Register now!
form the stock market & how ordinary people are
copying their strategies
No thanks
EPIX – essa pharma inc. (US:NASDAQ)
DELAYED
$
| Volume Shares | |
| 1 Day Range | |
| Volume Ratio | |
| 52 Week High | |
| 52 Week Low |
| VWAP | |
| Today’s Volatility | |
| 20 Days Volatility | |
| Open | |
| Prior Close |
1D
5D
1M
3M
YTD
1Y
3Y
1 Day
EPIX
SPY
QQQ
Swipe to see more
Main News & Impact Reports
Date
Time
Symbol
Headline
Impact
12/21
08:14 am
epix
When Will ESSA Pharma Inc. (NASDAQ:EPIX) Turn A Profit? [Yahoo! Finance]
Low
Report
When Will ESSA Pharma Inc. (NASDAQ:EPIX) Turn A Profit? [Yahoo! Finance]
12/17
07:26 am
epix
ESSA Pharma Provides Corporate Update and Reports Financial Results for Fiscal Fourth Quarter and Year Ended September 30, 2024 [Globe and Mail, The (Toronto, Canada)]
Low
Report
ESSA Pharma Provides Corporate Update and Reports Financial Results for Fiscal Fourth Quarter and Year Ended September 30, 2024 [Globe and Mail, The (Toronto, Canada)]
12/17
07:11 am
epix
ESSA Pharma Provides Corporate Update and Reports Financial Results for Fiscal Fourth Quarter and Year Ended September 30, 2024 [Yahoo! Finance]
Low
Report
ESSA Pharma Provides Corporate Update and Reports Financial Results for Fiscal Fourth Quarter and Year Ended September 30, 2024 [Yahoo! Finance]
12/17
07:11 am
epix
ESSA Pharma Provides Corporate Update and Reports Financial Results for Fiscal Fourth Quarter and Year Ended September 30, 2024 [Yahoo! Finance]
Low
Report
ESSA Pharma Provides Corporate Update and Reports Financial Results for Fiscal Fourth Quarter and Year Ended September 30, 2024 [Yahoo! Finance]
12/17
07:00 am
epix
ESSA Pharma Provides Corporate Update and Reports Financial Results for Fiscal Fourth Quarter and Year Ended September 30, 2024
Low
Report
ESSA Pharma Provides Corporate Update and Reports Financial Results for Fiscal Fourth Quarter and Year Ended September 30, 2024
12/3
07:23 pm
epix
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of ESSA Pharma Inc. - EPIX
Low
Report
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of ESSA Pharma Inc. - EPIX
11/27
12:00 pm
epix
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of ESSA Pharma Inc. - EPIX
Low
Report
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of ESSA Pharma Inc. - EPIX
11/26
04:30 pm
epix
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of ESSA Pharma Inc. - EPIX
Low
Report
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of ESSA Pharma Inc. - EPIX
Date
Time
Action
From
To
Firm
Impact
%Chg
Date
Time
Symbol
Headline
Impact
12/17
07:03 am
epix
Form 8-K ESSA Pharma Inc. For: Dec 17
Low
Report
Form 8-K ESSA Pharma Inc. For: Dec 17
12/17
07:01 am
epix
Form 10-K ESSA Pharma Inc. For: Sep 30
Low
Report
Form 10-K ESSA Pharma Inc. For: Sep 30
12/16
06:12 am
epix
Form 8-K ESSA Pharma Inc. For: Dec 12
Low
Report
Form 8-K ESSA Pharma Inc. For: Dec 12
12/6
07:01 am
epix
Form 8-K ESSA Pharma Inc. For: Jun 05
Neutral
Report
Form 8-K ESSA Pharma Inc. For: Jun 05
11/14
07:33 pm
epix
Form SC 13G/A ESSA Pharma Inc. Filed by: BB BIOTECH AG
Medium
Report
Form SC 13G/A ESSA Pharma Inc. Filed by: BB BIOTECH AG
11/14
04:05 pm
epix
Form SC 13G/A ESSA Pharma Inc. Filed by: PFM Health Sciences, LP
Low
Report
Form SC 13G/A ESSA Pharma Inc. Filed by: PFM Health Sciences, LP
11/14
06:56 am
epix
Form SC 13G/A ESSA Pharma Inc. Filed by: RTW INVESTMENTS, LP
Neutral
Report
Form SC 13G/A ESSA Pharma Inc. Filed by: RTW INVESTMENTS, LP
11/8
04:57 pm
epix
Form SC 13D ESSA Pharma Inc. Filed by: TANG CAPITAL MANAGEMENT LLC
Medium
Report
Form SC 13D ESSA Pharma Inc. Filed by: TANG CAPITAL MANAGEMENT LLC
Stock Stats
| News Stats | |
|---|---|
| All News | |
| News Wires | |
| Media Monitoring | |
| SEC Edgar Filings | |
| Upgrades | |
| Downgrades | |
| Initiated | |
| Reiterated | |
| Last Earnings | |
| Last Earnings EPS | |
| Next Earnings | |
| Order Stats |
|---|
| Sub-Penny |
|
|
| Odd lot |
|
|
| Avg. bid-ask spread |
|
|
| Avg. bid-ask size |
|
|
| Shares at ask/bid |
|
|
| Off exchange |
|
|
Main News & Impact Reports
TOP News Gainers
8/23
ESSA Pharma Announces $36 Million Public Offering of Common Stock and Concurrent Private Placement
27.9%
10/9 Form F-3 ESSA Pharma Inc. 9.4%
8/27 ESSA Pharma closes $36M capital raise [Seeking Alpha] 8.7%
9/19 ESSA to Present at Ladenburg Thalmann Healthcare Conference 7.0%
6/25 ESSA Pharma Inc. Reports Results of Annual General Meeting of Shareholders 6.9%
10/10 ESSA Pharma: Promising Novel Therapy For Treatment Of Prostate Cancer [Seeking Alpha] 6.2%
10/28 ESSA Pharma Presents Data on EPI-7386 at the AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics 5.7%
7/30 ESSA Announces Court Sanction of the Scheme of Arrangement with Realm Therapeutics 5.6%
3/2 Realtor Credits New Immunotherapy for Destroying the Cancer That Threatened His Life 5.6%
8/28 Form 6-K ESSA Pharma Inc. For: Aug 27 5.1%
10/9 Form F-3 ESSA Pharma Inc. 9.4%
8/27 ESSA Pharma closes $36M capital raise [Seeking Alpha] 8.7%
9/19 ESSA to Present at Ladenburg Thalmann Healthcare Conference 7.0%
6/25 ESSA Pharma Inc. Reports Results of Annual General Meeting of Shareholders 6.9%
10/10 ESSA Pharma: Promising Novel Therapy For Treatment Of Prostate Cancer [Seeking Alpha] 6.2%
10/28 ESSA Pharma Presents Data on EPI-7386 at the AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics 5.7%
7/30 ESSA Announces Court Sanction of the Scheme of Arrangement with Realm Therapeutics 5.6%
3/2 Realtor Credits New Immunotherapy for Destroying the Cancer That Threatened His Life 5.6%
8/28 Form 6-K ESSA Pharma Inc. For: Aug 27 5.1%
TOP News Decliners
7/31
Form 6-K ESSA Pharma Inc. For: Jul 31
-15.9%
5/16 ESSA Pharma Inc (NASDAQ: EPIX) was downgraded by analysts at Zacks Investment Research from a "hold" rating to a "sell" rating. -11.9%
5/28 Form 6-K ESSA Pharma Inc. For: May 24 -7.3%
5/10 Q2/2019 3/31/2019 EPS -0.540 ZacksConsensus -0.440 ActVsEst (0.100) - Miss -7.2%
8/23 ATGE, FL, FSLY and TELL among midday movers [Seeking Alpha] -4.3%
8/30 Form SC 13G ESSA Pharma Inc. Filed by: EVENTIDE ASSET MANAGEMENT, LLC -3.3%
5/23 Form SC 13D ESSA Pharma Inc. Filed by: EVENTIDE ASSET MANAGEMENT, LLC -2.8%
2/28 Form 6-K ESSA Pharma Inc. For: Feb 27 -2.2%
6/28 Form SC 13G/A ESSA Pharma Inc. Filed by: BIOTECHNOLOGY VALUE FUND L P -2.0%
7/8 Form 6-K ESSA Pharma Inc. For: Jul 08 -1.7%
5/16 ESSA Pharma Inc (NASDAQ: EPIX) was downgraded by analysts at Zacks Investment Research from a "hold" rating to a "sell" rating. -11.9%
5/28 Form 6-K ESSA Pharma Inc. For: May 24 -7.3%
5/10 Q2/2019 3/31/2019 EPS -0.540 ZacksConsensus -0.440 ActVsEst (0.100) - Miss -7.2%
8/23 ATGE, FL, FSLY and TELL among midday movers [Seeking Alpha] -4.3%
8/30 Form SC 13G ESSA Pharma Inc. Filed by: EVENTIDE ASSET MANAGEMENT, LLC -3.3%
5/23 Form SC 13D ESSA Pharma Inc. Filed by: EVENTIDE ASSET MANAGEMENT, LLC -2.8%
2/28 Form 6-K ESSA Pharma Inc. For: Feb 27 -2.2%
6/28 Form SC 13G/A ESSA Pharma Inc. Filed by: BIOTECHNOLOGY VALUE FUND L P -2.0%
7/8 Form 6-K ESSA Pharma Inc. For: Jul 08 -1.7%
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below: